StockTalk is a * video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses ASX health and biotechnology companies focused on fighting cancer.
Populating the expert panel this week is Tim Boreham, health & biotech journalist, Leslie Chong, CEO & managing director of Imugene (ASX:IMU) and Steven Yatomi-Clarke, CEO & managing director of Prescient Therapeutics (ASXTX).
The group discusses a range of topics, including appraising biotech stocks and valuing milestones, key development stages for oncology treatments, the importance of banking and M&A skills on biotech boards, key trends and investment hotspots and much more.
- Forums
- ASX - By Stock
- LC pro active investors interview
ASX small caps leading the fight against cancerStockhead TV2...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
-0.001(0.98%) |
Mkt cap ! $369.6M |
Open | High | Low | Value | Volume |
5.1¢ | 5.2¢ | 4.9¢ | $686.4K | 13.67M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 971000 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 1208118 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 945510 | 0.050 |
48 | 4990979 | 0.049 |
22 | 1506367 | 0.048 |
17 | 1117068 | 0.047 |
12 | 643607 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 1153950 | 19 |
0.052 | 1443622 | 8 |
0.053 | 2924852 | 10 |
0.054 | 1585794 | 6 |
0.055 | 1493417 | 11 |
Last trade - 13.40pm 08/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |